
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            External validation of precisebreast, a digital prognostic test for predicting breast cancer recurrence, in an early-stage cohort from the Netherlands - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152544D18AF30D330544D100327CB055.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="brcnres">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369158/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Breast Cancer Research : BCR">
<meta name="citation_title" content="External validation of precisebreast, a digital prognostic test for predicting breast cancer recurrence, in an early-stage cohort from the Netherlands">
<meta name="citation_author" content="Pieter J Westenend">
<meta name="citation_author_institution" content="Laboratory of Pathology, Dordrecht, Netherlands">
<meta name="citation_author" content="Claudia Meurs">
<meta name="citation_author_institution" content="Laboratory of Pathology, Dordrecht, Netherlands">
<meta name="citation_author" content="Gerardo Fernandez">
<meta name="citation_author_institution" content="PreciseDx, Inc., New York, NY USA">
<meta name="citation_author_institution" content="Mount Sinai Health System, New York, NY USA">
<meta name="citation_author" content="Marcel Prastawa">
<meta name="citation_author_institution" content="PreciseDx, Inc., New York, NY USA">
<meta name="citation_author" content="Abishek Sainath Madduri">
<meta name="citation_author_institution" content="PreciseDx, Inc., New York, NY USA">
<meta name="citation_author" content="Aaron Feliz">
<meta name="citation_author_institution" content="PreciseDx, Inc., New York, NY USA">
<meta name="citation_author" content="Juan Carlos Mejias">
<meta name="citation_author_institution" content="PreciseDx, Inc., New York, NY USA">
<meta name="citation_author" content="Alexander Shtabsky">
<meta name="citation_author_institution" content="PreciseDx, Inc., New York, NY USA">
<meta name="citation_author" content="Xiaozhu Zhang">
<meta name="citation_author_institution" content="PreciseDx, Inc., New York, NY USA">
<meta name="citation_author" content="Brandon Veremis">
<meta name="citation_author_institution" content="PreciseDx, Inc., New York, NY USA">
<meta name="citation_author_institution" content="Mount Sinai Health System, New York, NY USA">
<meta name="citation_author" content="Rebecca DeAngel">
<meta name="citation_author_institution" content="PreciseDx, Inc., New York, NY USA">
<meta name="citation_author" content="Michael J Donovan">
<meta name="citation_author_institution" content="PreciseDx, Inc., New York, NY USA">
<meta name="citation_author_institution" content="Mount Sinai Health System, New York, NY USA">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="27">
<meta name="citation_firstpage" content="152">
<meta name="citation_doi" content="10.1186/s13058-025-02104-8">
<meta name="citation_pmid" content="40836358">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369158/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369158/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369158/pdf/13058_2025_Article_2104.pdf">
<meta name="description" content="Current clinical guidelines recommend gene expression profiling to guide treatment in early-stage breast cancer. PreciseBreast (PDxBR) is a digital prognostic tool that integrates artificial intelligence (AI)-derived features from hematoxylin and ...">
<meta name="og:title" content="External validation of precisebreast, a digital prognostic test for predicting breast cancer recurrence, in an early-stage cohort from the Netherlands">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Current clinical guidelines recommend gene expression profiling to guide treatment in early-stage breast cancer. PreciseBreast (PDxBR) is a digital prognostic tool that integrates artificial intelligence (AI)-derived features from hematoxylin and ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369158/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12369158">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s13058-025-02104-8"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/13058_2025_Article_2104.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369158%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12369158/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12369158/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369158/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-brcnres.png" alt="Breast Cancer Research : BCR logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Breast Cancer Research : BCR" title="Link to Breast Cancer Research : BCR" shape="default" href="https://doi.org/10.1186/s13058-025-02104-8" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Breast Cancer Res</button></div>. 2025 Aug 20;27:152. doi: <a href="https://doi.org/10.1186/s13058-025-02104-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s13058-025-02104-8</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Breast%20Cancer%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Breast%20Cancer%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Breast%20Cancer%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Breast%20Cancer%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>External validation of precisebreast, a digital prognostic test for predicting breast cancer recurrence, in an early-stage cohort from the Netherlands</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Westenend%20PJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Pieter J Westenend</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Pieter J Westenend</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Pathology, Dordrecht, Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Westenend%20PJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Pieter J Westenend</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Meurs%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Claudia Meurs</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Claudia Meurs</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Pathology, Dordrecht, Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Meurs%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Claudia Meurs</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fernandez%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Gerardo Fernandez</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Gerardo Fernandez</span></h3>
<div class="p">
<sup>2</sup>PreciseDx, Inc., New York, NY USA </div>
<div class="p">
<sup>3</sup>Mount Sinai Health System, New York, NY USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fernandez%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gerardo Fernandez</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Prastawa%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Marcel Prastawa</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Marcel Prastawa</span></h3>
<div class="p">
<sup>2</sup>PreciseDx, Inc., New York, NY USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Prastawa%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marcel Prastawa</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Madduri%20AS%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Abishek Sainath Madduri</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Abishek Sainath Madduri</span></h3>
<div class="p">
<sup>2</sup>PreciseDx, Inc., New York, NY USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Madduri%20AS%22%5BAuthor%5D" class="usa-link"><span class="name western">Abishek Sainath Madduri</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Feliz%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Aaron Feliz</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Aaron Feliz</span></h3>
<div class="p">
<sup>2</sup>PreciseDx, Inc., New York, NY USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Feliz%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aaron Feliz</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mejias%20JC%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Juan Carlos Mejias</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Juan Carlos Mejias</span></h3>
<div class="p">
<sup>2</sup>PreciseDx, Inc., New York, NY USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mejias%20JC%22%5BAuthor%5D" class="usa-link"><span class="name western">Juan Carlos Mejias</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shtabsky%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Alexander Shtabsky</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Alexander Shtabsky</span></h3>
<div class="p">
<sup>2</sup>PreciseDx, Inc., New York, NY USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shtabsky%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexander Shtabsky</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Xiaozhu Zhang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Xiaozhu Zhang</span></h3>
<div class="p">
<sup>2</sup>PreciseDx, Inc., New York, NY USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaozhu Zhang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Veremis%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Brandon Veremis</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Brandon Veremis</span></h3>
<div class="p">
<sup>2</sup>PreciseDx, Inc., New York, NY USA </div>
<div class="p">
<sup>3</sup>Mount Sinai Health System, New York, NY USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Veremis%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Brandon Veremis</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22DeAngel%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Rebecca DeAngel</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Rebecca DeAngel</span></h3>
<div class="p">
<sup>2</sup>PreciseDx, Inc., New York, NY USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22DeAngel%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rebecca DeAngel</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Donovan%20MJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Michael J Donovan</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Michael J Donovan</span></h3>
<div class="p">
<sup>2</sup>PreciseDx, Inc., New York, NY USA </div>
<div class="p">
<sup>3</sup>Mount Sinai Health System, New York, NY USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Donovan%20MJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Michael J Donovan</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Laboratory of Pathology, Dordrecht, Netherlands </div>
<div id="Aff2">
<sup>2</sup>PreciseDx, Inc., New York, NY USA </div>
<div id="Aff3">
<sup>3</sup>Mount Sinai Health System, New York, NY USA </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 May 19; Accepted 2025 Aug 9; Issue date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12369158  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40836358/" class="usa-link">40836358</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Current clinical guidelines recommend gene expression profiling to guide treatment in early-stage breast cancer. PreciseBreast (PDxBR) is a digital prognostic tool that integrates artificial intelligence (AI)-derived features from hematoxylin and eosin (H&amp;E) slides with clinicopathologic data to predict recurrence risk. This study externally validated PDxBR in an independent cohort and compared its performance to other risk models.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">We retrospectively analyzed PDxBR in a cohort of 739 patients with early-stage hormone receptor-positive, HER2-negative breast cancer (median follow-up of 8.8 years). For each case, one H&amp;E-stained slide was digitized and analyzed to generate recurrence risk scores using the full PDxBR model, as well as image-only and clinical-only variants. A subset of patients who underwent MammaPrint testing was also evaluated. Model performance was assessed by AUC/C-index, hazard ratios, sensitivity, specificity, and negative and positive predictive values (NPV and PPV, respectively).</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">PDxBR showed prognostic accuracy in this external cohort (AUC/C-index 0.71, 95% CI: 0.66–0.75). Applying the PDxBR threshold (≥ 58 versus &lt; 58) yielded a hazard ratio of 3.05 (95% CI: 2.1–4.4, <em>p</em> &lt; 0.001), sensitivity 0.70, specificity 0.59, NPV 0.90, and PPV 0.27. PDxBR outperformed the modified Adjuvant! Online clinical model (MINDACT model, <em>p</em> &lt; 0.00001) and effectively reclassified grade 2 tumors into distinct risk groups.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par4">PDxBR demonstrated robust prognostic performance in an independent cohort, supporting its potential as a scalable, reproducible alternative to genomic assays for individualized risk stratification in early-stage breast cancer.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s13058-025-02104-8.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Early-stage breast cancer, Digital pathology, Artificial intelligence, Risk stratification, Prognostic model, Recurrence prediction, PreciseBreast</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par5">Current clinical practice guidelines from the American Society of Clinical Oncology (ASCO), National Comprehensive Cancer Network (NCCN), and European Society for Medical Oncology (ESMO) recommend comprehensive pathologic assessment of all excised invasive breast cancers, including gene expression profiling when relevant to therapeutic decision-making [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Although the global incidence of breast cancer has risen over the past two decades, with an estimated 2.3 million new cases and 670,000 breast cancer-related deaths in 2022 alone, survival rates have improved due to earlier detection and treatment advances [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Nevertheless, 10–30% of women with early-stage, estrogen receptor-positive (ER+) and human epidermal growth factor receptor 2-negative (HER2-) breast cancer will experience locoregional or distant recurrence, with approximately half of these events arising more than 5 years after the initial diagnosis [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Notably, these recurrence patterns align with reported rates of hormonal therapy resistance, which affect 30–50% of women with early-stage breast cancer [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>].</p>
<p id="Par6">In both the European Union (EU) and the United States (US), 60–70% of patients with early-stage breast cancer are hormone receptor-positive (HR+) and HER2-. These patients face a persistent risk of recurrence that can extend up to 20 years following diagnosis and treatment [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>], highlighting the need for accurate and individualized prognostic tools. Inaccurate risk estimation can result in overtreatment, leading to unnecessary systemic therapy exposure and associated toxicities, or undertreatment, potentially leading to preventable recurrence [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>].</p>
<p id="Par7">To address this challenge, a range of prognostic tools has been developed. Genomic assays such as MammaPrint and Oncotype DX integrate genomic, pathologic, and/or clinical data—such as patient age, tumor size, stage, grade, and lymph node status—to enhance individualized recurrence risk prediction and guide treatment decision-making [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Despite their value, these assays can be costly, tissue-intensive, and subject to logistical limitations, motivating the search for alternative methods that are more scalable and broadly accessible [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>].</p>
<p id="Par8">In this context, artificial intelligence (AI) and digital pathology have emerged as promising tools for extracting prognostic information from routinely collected hematoxylin and eosin (H&amp;E)-stained slides. These approaches can provide more objective, reproducible assessments of tumor morphology and microenvironmental features that may influence disease progression.</p>
<p id="Par9">One such application is PreciseBreast (PDxBR), a digital prognostic test that combines routinely available clinicopathologic variables (e.g., age, tumor size, stage and lymph node status) with AI-derived features extracted from whole-slide H&amp;E images of invasive breast cancer. The model generates a continuous risk score (0-100), which stratifies patients into low- and high-risk groups. In its initial development and validation study, PDxBR achieved a concordance index (C-index) of 0.75 and stratified patients between risk groups with a hazard ratio of 4.4 [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Thus, PDxBR not only standardizes histologic grading—which is notoriously prone to interobserver variability—but also enhances prognostic accuracy in a reproducible and cost-effective way [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. </p>
<p id="Par10">The current study aimed to externally validate PDxBR in an independent cohort of patients with early-stage HR + breast cancer from the Netherlands (NTH), managed according to ESMO and Dutch clinical guidelines. We also evaluated the performance of image-only (AI-grade) and clinical-only variants of the PDxBR model and compared these models to MammaPrint-based risk stratification in a subset of patients who underwent MammaPrint testing as part of routine care. This approach allowed us to assess the reproducibility of PDxBR prognostic performance over a median follow-up of 8.8 years, and its clinical relevance in comparison to existing genomic tools—mirroring the subgroup analysis in the original validation study with the 21-gene assay.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Study design and participants</h3>
<p id="Par11">We conducted a retrospective longitudinal validation study of the PDxBR prognostic model using an independent cohort of patients with early-stage breast cancer and a median follow-up of 8.8 years. The study cohort was identified by the site principal investigator (P.W.) at the Laboratory of Pathology, Albert Schweitzer Hospital, Dordrecht, NTH. Eligible patients were ≥ 23 years of age and had a diagnosis of infiltrating ductal carcinoma or mixed ductal and lobular carcinoma of the breast. Patients with a history of neoadjuvant therapy or prior breast cancer were excluded. Outcome data were obtained from electronic medical records at Albert Schweitzer Hospital and treatment data were accessed from the Dutch National Cancer Registry. A subset of high risk patients according to Adjuvant! Online (performed at time of diagnosis) were offered the option to have MammaPrint gene expression testing. Given the potential influence of this test on treatment decisions and outcomes, this subgroup was evaluated both as part of the total cohort and separately.</p>
<p id="Par12">Each patient was assigned a unique study identifier (ID), which was used to link digitized histology slides to the corresponding clinical data. H&amp;E-stained slides were scanned at 40X magnification using a Philips UltraFast slide scanner at the Philips facility in Eindhoven, NTH. The resulting digital images, labeled with study IDs, were then securely transferred to PreciseDx (New York, NY) via encrypted portable hard drives. All images were independently reviewed by three pathologists (A.S., B.V., and G.F.) to confirm the diagnosis of invasive breast cancer and to exclude tumors with pure lobular, mucinous, papillary, or metaplastic histology. These pathologists also verified tumor adequacy and image quality (minimum tumor diameter of &gt; 1 mm). All personnel involved in image review and analysis were blinded to patient outcomes.</p>
<p id="Par13">For each case, one representative image was selected for digital feature extraction using the PreciseDx digital analysis platform. The technical details regarding the development and validation of the PDxBR digital morphometric features and recurrence risk score have been previously published [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Briefly, digital biomarker features were derived to represent protein morphometric correlates of the Nottingham Grading System (NGS) for invasive breast cancer, including measures of tumor architecture, mitotic activity, and lymphocytic or mononuclear infiltrates [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. These features were integrated with clinical variables—including patient age, tumor size, anatomic stage, and lymph node status—using a validated algorithm to generate a PDxBR recurrence risk score, which classifies patients as low-risk (score of &lt; 58) or high-risk (score of ≥ 58) on a 0-100 scale. To compare the relative individual contribution of digital histology and clinical data, we also evaluated two additional models: an AI-grade image-only model (excluding clinical data) and a clinical-features-only model.</p>
<p id="Par14">De-identified clinical data—including patient demographics, clinicopathologic features, MammaPrint scores, adjuvant treatment, and outcomes—were abstracted by the NTH study investigator and independently reviewed by PreciseDx personnel for completeness and adjudication, in collaboration with staff located in NTH. Menopausal status was not available and was inferred based on age, with patients ≤ 50 years classified as premenopausal and those &gt; 50 years as postmenopausal.</p>
<p id="Par15">This study was approved for academic research use and was conducted under a data use agreement between Stichting Albert Schweitzer Ziekenhuis and PreciseDx, in accordance with the General Data Protection Regulation and applicable local data protection laws.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Statistical analyses</h3>
<p id="Par16">Performance of the PDxBr model was evaluated using the area under the curve (AUC)/C-index, Kaplan-Meier (KM) survival analysis, associated metrics and confidence intervals (CI), including negative predictive value (NPV), positive predictive value (PPV), hazard ratios, sensitivity, and specificity. The PDxBR model was compared to three alternate models: an AI-grade image-only model (PDxBR AI-grade), a PDxBR clinical model (PDxBR Clinical), and a clinical model based on a modified Adjuvant! Online in the MINDACT trial, (referred to as the MINDACT model for this publication), which included ER and HER2 status, histologic grade, and nodal status [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. The primary endpoint was median 8.8-year invasive disease-free survival, defined as freedom from locoregional recurrence, distant metastasis, and death from any cause. Cause-specific mortality could not be distinguished from overall survival in this cohort.</p>
<p id="Par17">This study followed the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) guidelines to ensure comprehensive and transparent reporting of predictive model development and validation.</p></section></section><section id="Sec5"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec6"><h3 class="pmc_sec_title">Patient and tumor characteristics</h3>
<p id="Par18">A total of 739 eligible participants with early-stage breast cancer were identified through the Albert Schweitzer Hospital Department of Pathology and the Dutch National Cancer Registry. The median age was 61 years, with 78% of patients over 50 years, and a majority (~ 85%) identified as White. Of the excised tumors, 645 (87%) were ≤ 2.5 cm, 729 (99%) were anatomic stage I or II, 587 (79%) were node-negative (N0), 381 (52%) were histologic grade 2, 739 (100%) were ER+, and 739 (100%) were HER2- (Table <a href="#Tab1" class="usa-link">1</a>).</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Demographics of NTH cohort</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Characteristic, <em>n</em> (%)</th>
<th align="left" colspan="1" rowspan="1">
<em>N</em> = 739</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Age at Diagnosis (years)</strong>, median (SD)</td>
<td align="left" colspan="1" rowspan="1">61 (29–91)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Age ≤ 50</td>
<td align="left" colspan="1" rowspan="1">160 (21.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Age &gt; 50</td>
<td align="left" colspan="1" rowspan="1">579 (78.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Tumor Size (cm)</strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≤2.5</td>
<td align="left" colspan="1" rowspan="1">645 (87.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &gt;2.5 and ≤ 5</td>
<td align="left" colspan="1" rowspan="1">86 (11.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &gt;5</td>
<td align="left" colspan="1" rowspan="1">8 (1.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Anatomic Stage</strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> I</td>
<td align="left" colspan="1" rowspan="1">454 (61.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> II</td>
<td align="left" colspan="1" rowspan="1">275 (37.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> III</td>
<td align="left" colspan="1" rowspan="1">9 (1.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> IV</td>
<td align="left" colspan="1" rowspan="1">1 (0.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Positive Lymph Nodes</strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 0</td>
<td align="left" colspan="1" rowspan="1">587 (79.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 1–3</td>
<td align="left" colspan="1" rowspan="1">152 (20.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Tumor Grade</strong>
<sup><strong>+</strong></sup>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 1</td>
<td align="left" colspan="1" rowspan="1">266 (36.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 2</td>
<td align="left" colspan="1" rowspan="1">381 (51.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 3</td>
<td align="left" colspan="1" rowspan="1">86 (11.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>ER Status</strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="left" colspan="1" rowspan="1">739 (100.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>PR Status</strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="left" colspan="1" rowspan="1">648 (87.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="left" colspan="1" rowspan="1">75 (10.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> NA</td>
<td align="left" colspan="1" rowspan="1">16 (2.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>HER2 Status</strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="left" colspan="1" rowspan="1">739 (100.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Prior Treatments</strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Chemotherapy</td>
<td align="left" colspan="1" rowspan="1">214 (29.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Endocrine Therapy</td>
<td align="left" colspan="1" rowspan="1">475 (64.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Radiation Therapy</td>
<td align="left" colspan="1" rowspan="1">503 (68.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Total Events</strong>
</td>
<td align="left" colspan="1" rowspan="1">130 (17.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Locoregional Recurrences/Second Primaries</td>
<td align="left" colspan="1" rowspan="1">24 (3.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Distant Metastases</td>
<td align="left" colspan="1" rowspan="1">25 (3.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Deaths</td>
<td align="left" colspan="1" rowspan="1">81 (11.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Risk Group Stratification</strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong><em>Prior MammaPrint Analysis</em></strong>
<strong>*</strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Low-risk</td>
<td align="left" colspan="1" rowspan="1">166 (65.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> High-risk</td>
<td align="left" colspan="1" rowspan="1">86 (34.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Unknown</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong><em>PDxBR</em></strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Low-risk</td>
<td align="left" colspan="1" rowspan="1">400 (54.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> High-risk</td>
<td align="left" colspan="1" rowspan="1">339 (45.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong><em>PDxBR Clinical</em></strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Low-risk</td>
<td align="left" colspan="1" rowspan="1">479 (64.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> High-risk</td>
<td align="left" colspan="1" rowspan="1">260 (35.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong><em>PDxBR AI-grade</em></strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Low-risk</td>
<td align="left" colspan="1" rowspan="1">372 (50.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> High-risk</td>
<td align="left" colspan="1" rowspan="1">367 (49.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Follow-Up Time (months)</strong>, median (range)</td>
<td align="left" colspan="1" rowspan="1">105.5 (2.4-160.7)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p22">
<p>*<em>n</em> = 252 patients with MammaPrint Results; <sup>+</sup>, histologic grade was not available for 6 patients</p>
<p>AI, artificial intelligence; cm, centimeters; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; NA, not available; PDxBR, PreciseBreast; PR, progesterone receptor</p>
</div></div></section><p id="Par20">Prior treatments included chemotherapy in 214 (29%) patients, endocrine therapy in 475 (64%), and radiation therapy in 503 (68%) (Table <a href="#Tab1" class="usa-link">1</a>). The absence of endocrine therapy in 36% of the overall cohort was not unexpected, as Dutch guidelines differ from ESMO recommendations. Approximately 70% of this group had radiation and/or chemotherapy. Specifically, endocrine therapy is not advised for patients over 34 years with N0/N0(i+) disease and grade 1 tumors up to 2 cm or grade 2–3 tumors up to 1 cm, or for patients under 35 years of age with N0/N0(i+) disease and grade 1 tumors up to 1 cm.</p>
<p id="Par21">Among the 739 patients, there were 130 (18%) recurrence or survival events over the median follow-up time of 8.8 years: 24 (3.3%) locoregional recurrences or second primaries, 25 (3.4%) distant metastases, and 81 (11.0%) deaths (Table <a href="#Tab1" class="usa-link">1</a>). Among the 25 patients with distant metastases, 76% were &gt; 50 years, 68% had tumors &lt; 2.5 cm, 72% were N0, 92% were stage I or II, 60% were histological grade 2, 100% received endocrine therapy, and 60% received chemotherapy (data not shown). Of the 739 total patients, 252 (34.1%) received MammaPrint testing, of which 166 (65.9%) were classified as low-risk and 86 (34.1%) were classified as high-risk (Table <a href="#Tab1" class="usa-link">1</a>).</p></section><section id="Sec7"><h3 class="pmc_sec_title">Performance of PreciseBreast</h3>
<p id="Par22">The PDxBR model identifies the number of positive lymph nodes and patient age at diagnosis as the most predictive clinical variables for breast cancer recurrence, while tubule formation (glandular architecture) and tumor-infiltrating lymphocytes are the most influential image-derived features [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. A SHapley Additive exPlanations (SHAP) plot detailing the differential weighting and contribution of individual morphological features of the AI-grade model output is presented in Supplemental Figure <a href="#MOESM1" class="usa-link">S1</a>. Of importance, gland differentiation has a 29.1% absolute contribution to the PDxBR score (encompassing tubule formation [20.7%], neighboring nuclei [4.4%], and sheets [4.0%]), while nuclear pleomorphism represents 13.7% and mitotic figure count is at 8.2%. Collectively, the imaging features accounted for 51% of the PreciseBreast score. A univariate Cox proportional hazards model and C-index analysis identified gland architecture as one of the most informative components of the PDxBR model along with the independent contribution of nuclear pleomorphism and mitotic figures (Supplemental Table <a href="#MOESM1" class="usa-link">S1</a>). Notably, although both HR status and histologic grade were among the offered variables during model development, they were excluded during feature selection, suggesting that their prognostic value was subsumed by the AI-derived morphologic features.</p>
<p id="Par23">The clinical relevance of these AI-derived features is illustrated by two cases that were misclassified as low-risk by both MammaPrint and the MINDACT model but correctly identified as high-risk by the PDxBR model (Fig. <a href="#Fig1" class="usa-link">1</a>). In both cases, patients with ER+/HER2- tumors experienced recurrence—one distant and one locoregional—despite being assigned to low-risk groups by traditional tools. These examples underscore the ability of PDxBR to identify high-risk patients through AI-derived morphologic features that may be overlooked by existing clinical and genomic models.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369158_13058_2025_2104_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7028/12369158/be7a2c4e7712/13058_2025_2104_Fig1_HTML.jpg" loading="lazy" id="d33e774" height="1015" width="748" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Representative H&amp;E-stained sections of patients misclassified as low-risk by MammaPrint and the MINDACT model but correctly stratified as high-risk by PreciseBreast. (<strong>A</strong>) Patient 1, aged 62 with stage I/II invasive breast cancer (tumor size 1.2 cm, grade 2, N0) who developed a distant metastasis. PreciseBreast score was 67.8 and classified as high-risk by the PDxBR AI-grade model. (<strong>B</strong>) Patient 2, aged 55 with stage I/II invasive breast cancer (tumor size 1.1 cm, grade 3, N0) and a locoregional recurrence. Her PreciseBreast borderline low-risk score of 56 (risk threshold: 58) and was classified as high-risk by the PDxBR AI-grade model. Both patients had ER+/PR+/HER2- tumors. For each case, panel 1 shows mitotic figure detection (yellow boxes with green inset boxes), and panel 2 shows an H&amp;E section that in panel 3 displays gland architecture overlay used to assess tubule formation</p></figcaption></figure><p id="Par25">Building on these insights, we assessed the overall performance of PDxBR and its component models in the full NTH cohort (<em>n</em> = 739). PDxBR demonstrated an AUC/C-index of 0.71 (95% CI: 0.66–0.75) (Table <a href="#Tab2" class="usa-link">2</a>), compared to the original validation study which had an AUC/C-index of 0.75 (95% CI: 0.72–0.79) [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. The PDxBR AI-grade model and clinical model yielded AUC/C-indices of 0.66 (95% CI: 0.62–0.71) and 0.69 (95% CI: 0.65–0.74), respectively. The MINDACT model [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>], which incorporates ER status, HER2 status, histological grade, tumor size, and nodal status, had an AUC/C-index of 0.60 (95% CI: 0.56–0.64). We further evaluated the performance of the PDxBR model to the PDxBRAI-grade and PDxBR clinical models using DeLong’s test for paired C-index comparison. The PDxBR model significantly outperformed PDxBR AI-grade (<em>p</em> &lt; 0.0001), while the PDxBR versus PDxBR clinical showed no statistical difference (<em>p</em> = 0.49). Furthermore, performance of the PDxBR clinical versus PDxBR AI-grade model was not statistically different (<em>p</em> = 0.076), although trending towards significance. Collectively, these results support prognostic superiority when both clinical and imaging features are algorithmically combined to risk stratify patients.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Multi-model risk performance in the NTH cohort</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Test</th>
<th align="left" colspan="1" rowspan="1">C-Index<br>(95% CI)</th>
<th align="left" colspan="1" rowspan="1">Hazard Ratio<br>(95% CI)</th>
<th align="left" colspan="1" rowspan="1">SE<br>(95% CI)</th>
<th align="left" colspan="1" rowspan="1">SP<br>(95% CI)</th>
<th align="left" colspan="1" rowspan="1">PPV<br>(95% CI)</th>
<th align="left" colspan="1" rowspan="1">NPV<br>(95% CI)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>MammaPrint</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.52</p>
<p>(0.39–0.65)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>1.19</p>
<p>(0.43–3.29)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.38</p>
<p>(0.18–0.62)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.66</p>
<p>(0.6–0.72)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.07</p>
<p>(0.03–0.15)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.94</p>
<p>(0.89–0.97)</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>PDxBR</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.71</p>
<p>(0.66–0.75)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>3.05</p>
<p>(2.10–4.44)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.70</p>
<p>(0.62–0.77)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.59</p>
<p>(0.55–0.63)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.27</p>
<p>(0.22–0.32)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.90</p>
<p>(0.87–0.93)</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>PDxBR AI-grade</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.66</p>
<p>(0.62–0.71)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>2.87</p>
<p>(1.96–4.19)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.71</p>
<p>(0.62–0.78)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.55</p>
<p>(0.51–0.59)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.25</p>
<p>(0.21–0.30)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.90</p>
<p>(0.86–0.92)</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>PDxBR Clinical</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.69</p>
<p>(0.65–0.74)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>2.98</p>
<p>(2.10–4.24)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.60</p>
<p>(0.51–0.68)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.70</p>
<p>(0.66–0.74)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.30</p>
<p>(0.25–0.36)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.89</p>
<p>(0.86–0.92)</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>
<strong>MINDACT</strong>
</p>
<p>
<strong>Model</strong>
</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.60</p>
<p>(0.56–0.64)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>2.17</p>
<p>(1.54–3.06)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.52</p>
<p>(0.44–0.61)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.68</p>
<p>(0.64–0.72)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.26</p>
<p>(0.21–0.31)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.87</p>
<p>(0.84–0.90)</p>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p95"><p>AI, artificial intelligence; CI, confidence interval; NPV, negative predictive value; NTH, The Netherlands; PDxBR, PreciseBreast; PPV, positive predictive value; SE, sensitivity; SP, specificity</p></div></div></section><p id="Par27">An exploratory model incorporating only histologic grade and tumor size demonstrated an AUC/C-index of 0.60 (95% CI: 0.56-0.64), identical to that of MINDACT (data not shown). An AUC comparison of all models demonstrated that PDxBR significantly outperformed the MINDACT model (DeLong test <em>p</em> &lt; 0.00001 (Fig. <a href="#Fig2" class="usa-link">2</a>).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369158_13058_2025_2104_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7028/12369158/384f737a31e5/13058_2025_2104_Fig2_HTML.jpg" loading="lazy" id="d33e1000" height="491" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>AUC comparison of model performance for predicting breast cancer recurrence within a 6-year period. The DeLong test was used to assess statistical differences between AUCs: PDxBR (C-index = 0.71), PDxBR Clinical (0.69), PDxBR AI-grade (0.66), MINDACT (0.60), and MammaPrint (0.52). PDxBR significantly outperformed MammaPrint (<em>n</em> = 252, <em>p</em> = 0.0004) and the MINDACT model (<em>p</em> &lt; 0.00001). The PDxBR Clinical model also significantly outperformed MINDACT (<em>p</em> &lt; 0.00001), further supporting its enhanced prognostic accuracy.</p></figcaption></figure><p id="Par29">Using a risk score cutoff of 58 (&lt; 58 = low-risk, ≥ 58 = high-risk), PDxBR stratified patients with a hazard ratio of 3.05 (95% CI: 2.1–4.4, <em>p</em> &lt; 0.001), sensitivity of 0.70, specificity of 0.59, NPV of 0.90, and PPV of 0.27 for predicting breast cancer recurrence (Table <a href="#Tab2" class="usa-link">2</a>). These results were consistent with those observed in the original validation study, which reported a hazard ratio of 4.4 (95% CI: 2.7–7.1, <em>p</em> &lt; 0.001), sensitivity of 0.61, specificity of 0.77, NPV of 0.94, and PPV of 0.24 [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>].</p>
<p id="Par30">In the NTH cohort, PDxBR classified 400 (54%) patients as low-risk and 339 (46%) as high-risk (Table <a href="#Tab1" class="usa-link">1</a>). KM survival analysis of the NTH cohort demonstrated a significant difference in predicted invasive disease-free survival between PDxBR-defined risk groups, with high-risk patients displaying a significantly lower survival probability compared to those classified as low-risk (Fig. <a href="#Fig3" class="usa-link">3</a>, <em>p</em> &lt; 0.0001).</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369158_13058_2025_2104_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7028/12369158/2362c3eabbf3/13058_2025_2104_Fig3_HTML.jpg" loading="lazy" id="d33e1045" height="643" width="669" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan-Meier analysis of invasive disease-free survival stratified by PDxBR risk score in the NTH Cohort. Patients classified as high-risk (<em>n</em> = 339) had significantly worse predicted invasive disease-free survival compared to those classified at low-risk (<em>n</em> = 400) over a median follow-up of 8.8 years (<em>p</em> &lt; 0.0001). Risk tables show the number of patients at risk over time in each group.</p></figcaption></figure><p id="Par32">The NTH cohort included 130 recurrence events, of which 91 (70%) were classified as high-risk by PDxBR (including 61 deaths, 16 metastases, and 14 locoregional or second primary recurrences), compared to 68 (52%) events classified as high-risk by the MINDACT model. Detailed model performance metrics and event types are provided in Table <a href="#Tab2" class="usa-link">2</a> and Supplemental Table <a href="#MOESM1" class="usa-link">S2</a>, respectively. Across the entire 739 patient cohort, 125 patients who experienced an event were classified as low-risk according to the MINDACT model, but high-risk by PDxBR. In contrast, only 34 patients with an event were classified as high-risk by MINDACT model and low-risk by PDxBR. Thus, overall PDxBR exhibited good risk stratification and event discrimination when compared to the MINDACT model.</p>
<p id="Par33">By comparison, the original validation cohort had 69 recurrence events, with 39 (57%) classified as high risk [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Moreover, the longer median follow-up period in the NTH cohort (8.8 years versus 6 years in the original validation study), along with higher event counts—81 versus 32 deaths, 25 versus 20 distant metastases, and 24 versuss 17 locoregional or second primary recurrences (Table <a href="#Tab1" class="usa-link">1</a>) provides valuable contextual insight.</p>
<p id="Par34">We also evaluated PDxBR performance specifically in patients who developed distant metastases (<em>n</em> = 25). Among these, the majority of metastatic events in PDxBR high-risk patients occurred after 5 years of follow-up (Supplemental Figure <a href="#MOESM1" class="usa-link">S2</a>).</p></section><section id="Sec8"><h3 class="pmc_sec_title">AI-grade and clinical model performance</h3>
<p id="Par35">The PDxBR AI-grade and clinical models yielded hazard ratios of 2.87 (95% CI: 1.96–4.19) and 2.98 (95% CI: 2.1–4.24), respectively (Table <a href="#Tab2" class="usa-link">2</a>). Both models demonstrated similar NPVs of 0.90 and 0.89, and PPVs of 0.25 and 0.30, respectively. Notably, the AI-grade high-risk model identified 92 (71% of all 130 events), including 21 (84%) metastases and 13 (54%) recurrences (Supplemental Table <a href="#MOESM1" class="usa-link">S2</a>). KM survival analysis of the NTH cohort by both the PDxBR AI-grade (Fig. <a href="#Fig4" class="usa-link">4</a>A) and PDxBR Clinical models (Fig. <a href="#Fig4" class="usa-link">4</a>B) also demonstrated a significant difference in predicted invasive disease-free survival between risk groups in the NTH cohort, with high-risk patients displaying a significantly worse survival probability compared to those classified as low-risk.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369158_13058_2025_2104_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7028/12369158/f533bb19921e/13058_2025_2104_Fig4_HTML.jpg" loading="lazy" id="d33e1122" height="1269" width="686" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan-Meier analysis of invasive disease-free survival stratified by PDxBR AI-grade and Clinical model risk scores in the NTH cohort. (<strong>A</strong>) In the PDxBR AI-grade image-only model, patients classified as high-risk (<em>n</em> = 367) had significantly worse predicted invasive disease-free survival compared to those classified as low-risk (<em>n</em> = 372) over a median follow-up of 8.8 years (<em>p</em> &lt; 0.0001). (<strong>B</strong>) In the PDxBR Clinical model, patients classified as high-risk (<em>n</em> = 260) had significantly worse predicted invasive disease-free survival compared to those classified as low-risk (<em>n</em> = 479) over a median follow-up of 8.8 years (<em>p</em> &lt; 0.0001). Risk tables show the number of patients at risk over time in each group.</p></figcaption></figure><p id="Par37">When evaluating performance specifically for predicting distant metastases, the AI-grade model produced a hazard ratio of 6.35 (95% CI: 2.17–18.53) and a sensitivity of 0.84. The NPVs for the PDxBR, PDxBR AI-grade, and PDxBR Clinical models were 0.98, 0.99, and 0.98, respectively (Supplemental Table <a href="#MOESM1" class="usa-link">S3</a>).</p>
<p id="Par38">As noted in Table <a href="#Tab1" class="usa-link">1</a>, only 475 (64%) of all patients received endocrine therapy and 214 (29%) received chemotherapy. Treatment patterns were consistent with clinical risk as defined by MINDACT criteria: 92% (243/263) of high-risk patients received endocrine therapy and 51% (133/263) received chemotherapy. In comparison, among those classified as high-risk via PDxBR, 81% (275/339) received endocrine therapy and 32% (107/339) chemotherapy. Finally, of the 25 patients who developed distant metastases, 18 (72%) received endocrine therapy and 13 (48%) received chemotherapy (data not shown).</p></section><section id="Sec9"><h3 class="pmc_sec_title">Use of PDxBR and PDxBR AI-grade to redistribute NGS grade</h3>
<p id="Par39">The PDxBR model has previously demonstrated the ability to recategorize patients graded under the NGS three-tier system into binary low- versus high-risk categories. As such, this yielded an AUC analysis over a 5-year period comparing histologic grade versus AI-grade and demonstrated good discrimination with a DeLong <em>p</em> &lt; 0.001 (Supplemental Figure <a href="#MOESM1" class="usa-link">S3</a>). The redistribution of histologic grading with the AI-grade model in Supplemental Table <a href="#MOESM1" class="usa-link">S4</a> further illustrates the ability to provide an objective assessment of grade 1 and 3 tumors while highlighting the higher risk associated with the grade 2 category. Further, the reclassification is particularly relevant for grade 2 tumors, which accounted for 52% (381/739) of the total study population (Table <a href="#Tab1" class="usa-link">1</a>). Of these, PDxBR reclassified 175 (46%) as low-risk and 206 (54%) as high-risk. Similarly, 195 of 266 (73%) patients with grade 1 tumors were classified as low-risk and 61 of 86 (71%) patients with grade 3 tumors as high-risk.</p>
<p id="Par40">When applying the PDxBR AI-grade model, patients with grade 2 tumors were more evenly distributed between risk categories, with the majority of grade 1 and grade 3 tumors classified as low-risk (76%) and high-risk (81%), respectively. Given that grade 2 tumors are generally (clinically) considered higher risk, we arbitrarily combined histologic grades 2 and 3 into a single high-risk category (blue line, Fig. <a href="#Fig5" class="usa-link">5</a>) vs. low-risk that consisted of grade 1 tumors (brown line) and compared them to a robust PDxBR AI-grade high-risk (red line) and low-risk (green line) categorization, beyond traditional histologic grading (Fig<a href="#Fig5" class="usa-link">5</a>). Next, we performed KM survival analyses for low-grade versus low-risk PDxBR AI-grade and high-grade versus high-risk PDxBR AI-grade groups. No statistical difference in survival between either grouping was determined (Supplemental Figure <a href="#MOESM1" class="usa-link">S4</a>A, <em>p</em> = 0.38 and Figure <a href="#MOESM1" class="usa-link">S4</a>B, <em>p</em> = 0.59, respectively). Lastly, we conducted a KM survival analysis restricted to patients with grade 2 tumors stratified by PDxBR low- and high-risk classification and observed a significant difference in recurrence-free survival between groups (log-rank <em>p</em> = 0.00017, HR = 2.74 (95% CI:1.59–4.73), Supplemental Figure <a href="#MOESM1" class="usa-link">S5</a>). In addition, the PDxBR AI-grade model identified 21 of 25 patients with metastatic events, compared to 16 and 17 identified by the PDxBR and MINDACT models, respectively (Supplemental Table <a href="#MOESM1" class="usa-link">S2</a>).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369158_13058_2025_2104_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7028/12369158/38257db76877/13058_2025_2104_Fig5_HTML.jpg" loading="lazy" id="d33e1188" height="565" width="669" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Histologic versus PDxBR AI-grade on the 739 patients in the NTH cohort. Histologic tumor grades 2 and 3 were merged into a single high-risk category (blue line, Grade) vs. low-risk that consisted of grade 1 tumors only (brown line, Grade). This was compared to the PDxBR AI-grade high-risk (red line) and low-risk (green line) categorization, which stratifies risk beyond traditional histologic grading.</p></figcaption></figure></section><section id="Sec10"><h3 class="pmc_sec_title">Evaluation of the MammaPrint subgroup with PreciseBreast</h3>
<p id="Par42">To further assess PDxBR performance, we evaluated a subgroup of 252 patients who had previously undergone MammaPrint testing. In this cohort, MammaPrint was used to both predict risk of distant recurrence and to guide adjuvant treatment decisions. As a result, the outcomes from this analysis may be biased towards the PDxBR risk assessment tool. This group had clinicopathologic characteristics like the overall cohort of 739 patients, with a median age of 57 years (73% aged &gt; 50), 99% with stage I or II disease, 84% N0, 66.7% with grade 2 tumors, and 100% HR+/HER2- status (Supplemental Table <a href="#MOESM1" class="usa-link">S5</a>). There were 16 (6%) events, comprising 4 locoregional recurrences, 5 metastases, and 7 deaths. Median follow-up was 5 years for all patients versus 4 years for the 16 patients with events. Most of these patients were &gt; 50 years of age (88%), 94% had tumors ≤ 2.5 cm, 88% were N0, and 94% had grade 1 tumors.</p>
<p id="Par43">The AUC/C-index of MammaPrint in this subgroup was 0.52 (95% CI: 0.39–0.65), compared to 0.51 (95% CI: 0.41–0.61) for PDxBR (Table <a href="#Tab2" class="usa-link">2</a> and Supplemental Table <a href="#MOESM1" class="usa-link">S6</a>). Among the NTH cohort with available MammaPrint results, 166 (66%) patients were classified as low-risk and 86 (34%) as high-risk (Table <a href="#Tab1" class="usa-link">1</a>). Of the 86 MammaPrint-classified high-risk patients, 70 (81%) received adjuvant chemotherapy and 82 (95%) received endocrine therapy, while among low-risk patients, 5 (3%) received chemotherapy and 134 (81%) received endocrine therapy.</p>
<p id="Par44">MammaPrint identified 6 of 16 events (3 deaths, 3 metastases) in its high-risk group (Supplemental Table <a href="#MOESM1" class="usa-link">S7</a>), whereas PDxBR identified 5 of 16 events (2 deaths, 2 metastases, 1 recurrence) in its high-risk group (<em>n</em> = 107) (Supplemental Table <a href="#MOESM1" class="usa-link">S8</a>). PDxBR AI-grade high-risk identified 10 of 16 events (5 deaths, 3 metastases, 2 recurrences), while PDxBR Clinical high-risk identified 3 events (1 death, 1 metastasis, 1 recurrence).</p>
<p id="Par45">The hazard ratio for MammaPrint was 1.19, with an NPV of 0.94 and PPV of 0.07 (Supplemental Table <a href="#MOESM1" class="usa-link">S6</a> and Supplemental Figure <a href="#MOESM1" class="usa-link">S6</a>, <em>p</em> = 0.73). In comparison, PDxBR had a hazard ratio of 0.55, NPV of 0.92, and PPV of 0.05. In contrast, the PDxBR AI-grade model had a hazard ratio of 1.28, with an NPV of 0.95 and PPV of 0.07. These results promote the potential for PDxBR AI-grade to provide independent prognostic value in patient risk stratification.</p></section></section><section id="Sec11"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par46">We previously validated the prognostic digital assay, PreciseBreast (PDxBR), for its ability to predict the likelihood of invasive breast cancer recurrence within six years following surgical excision [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. This approach integrates a novel AI-derived tumor grading system—based on morphological and protein expression features from pathology images—with standard clinicopathological variables (age, tumor size, stage, and lymph node status) to predict invasive disease-free survival, with an AUC of 0.76, NPV of 0.94 and PPV of 0.24 [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. To expand on these initial findings, we evaluated the performance of PDxBR in an independent cohort of early-stage breast cancer patients from NTH, followed for a median of 8.8 years. Compared to the original validation cohort [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>], the NTH population represented a lower-risk population, with no cases of combined HER2 + and triple-negative breast cancer, in contrast to the 20% in the original cohort. Despite this, the NTH cohort experienced a slightly higher event rate (16% versus 14%), possibly due to differences in follow-up duration (8.8 versus 6 years).</p>
<p id="Par47">PDxBR demonstrated similar predictive performance of recurrence risk across both cohorts. In the NTH dataset, the PDxBR model achieved an AUC/C-index of 0.71 (95% CI: 0.66–0.75), compared to 0.75 (95% CI: 0.72–0.79) in the original validation study [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. The PDxBR AI-grade model yielded an AUC/C-index of 0.66 (95% CI: 0.62–0.71) and the PDxBR Clinical model an index of 0.69 (95% CI: 0.65–0.74), versus 0.67 (95% CI: 0.63–0.71) and 0.71 (95% CI: 0.66–0.76), respectively, in the original cohort. In contrast, a model based on features used in the MINDACT trial (e.g., HR/HER2 status, histologic grade, tumor size, and nodal status), produced a lower AUC/C-index of 0.60 (95% CI: 0.56–0.64). These results highlight the need for standardized methods for optimized breast cancer prognostication [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>].</p>
<p id="Par48">When NTH patients were stratified using PDxBR risk score (≥ 58 versus &lt; 58), the model yielded a hazard ratio of 3.05 ([95% CI: 2.1–4.4], <em>p</em> &lt; 0.001), with a sensitivity of 0.70, specificity of 0.59, NPV of 0.90, and PPV of 0.27 for predicting breast cancer recurrence. The original validation study reported a hazard ratio of 4.4 ([95% CI: 2.7–7.1], <em>p</em> &lt; 0.001), with a sensitivity of 0.60, specificity of 0.77, NPV of 0.94, and PPV of 0.24 [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. As expected, the NPV and PPV varied between cohorts, reflecting differences in population characteristics, event frequency and types, and follow-up duration. For example, the rates of recurrence, metastasis, and death differed between the NTH and original cohorts (recurrence: 3.3% versus 25%; metastasis: 3.4% versus 29%; deaths: 11% versus 46%). Despite these differences, PDxBR successfully identified 91 of 130 (70%) patients with events as high-risk in the NTH cohort, compared to 70 of 130 (54%) patients using the clinical model from the MINDACT trial. These findings further support the robustness of PDxBR in stratifying recurrence risk across distinct patient populations.</p>
<p id="Par49">The American Joint Committee on Cancer (AJCC) 8th and 9th edition staging manuals now incorporate prognostic staging for breast cancer, where histologic grade remains a factor—alongside estrogen and progesterone receptor status, HER2 amplification, and select molecular assays—in assessing recurrence risk. However, histologic grading remains a subjective process, with strong interobserver agreement only for grade 1 tumors, and moderate to fair agreement for grades 2 and 3 [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. This poses a particular challenge in the NTH cohort, where grade 2 tumors account for 52% of cases. We previously demonstrated that both the PDxBR and PDxBR AI-grade models could resolve this ambiguity by subdividing grade 2 tumors into biologically meaningful low- and high-risk categories. This was confirmed in the NTH cohort, where the 381 patients with grade 2 disease were reclassified by PDxBR into 175 (46%) low-risk and 206 (54%) high-risk groups, with a similar even split using the AI-grade model. These results suggest that reclassifying grade 2 tumors using the AI-grade model—and stabilizing classification for grades 1 and 3—may provide a more objective and accurate basis for risk stratification, thereby enhancing precision in prognostic assessment.</p>
<p id="Par50">Clinical risk remains a critical component of individualized breast cancer management, as evidenced by tools like RSClin and RSClin + for Oncotype DX [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>], and the EndoPredict 12-gene assay, which integrates molecular data with tumor size and nodal status to generate the EPclin score [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. In this context, we developed an objective tool that quantifies and standardizes readily available clinicopathologic variables (e.g., age, tumor size, stage, and lymph node status) and integrates these with seven morphological features (AI-grade) associated with biological quiescence, disorder, resistance mechanisms, proliferation, and immune response [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>].</p>
<p id="Par51">The comparable performance of the PDxBR Clinical model and the MINDACT trial algorithm further highlights the potential of AI-driven grading to standardize clinical risk assessment, which has historically relied on heuristic and often subjective measures. Our objective is to improve risk stratification for all patients with early-stage invasive breast cancer by introducing interpretable, scalable methodologies that can be seamlessly integrated into routine clinical care. Other groups are developing assays to predict breast cancer recurrence by interrogation of H&amp;E stained whole slide images of invasive breast cancer (IBC). The approaches vary from applying standard histologic grades to identify and train digital features that improve risk discrimination for intermediate grading [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>], to constructing foundational self-supervised machine learning models that collectively assess the IBC phenotype and combine these attributes with clinical data to predict risk of recurrence [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>].</p>
<p id="Par52">While our findings support the robustness and clinical utility of PDxBR, several limitations should be considered when interpreting the results. There were notable differences in outcomes and event distributions between the original validation study and the NTH cohort, particularly the longer median follow-up in the NTH cohort (6 versus 8.8 years), as well as a higher number of deaths (32 versus 80) and metastases (20 versus 25). To address the potential for performance bias, we analyzed all event categories—both individually and collectively—across all models, including the subgroup of 252 patients who were also evaluated with MammaPrint. Moreover, the MammaPrint cohort was not designed to independently predict systemic therapy (by MammaPrint) and assess risk for possible events. Additionally, the study design was unable to determine cause-specific mortality, a constraint shared with the original validation study. Finally, since the NTH does not routinely perform Ki67 staining, we were not able to assess its impact on outcome prediction in this patient cohort.</p></section><section id="Sec12"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par53">In this external validation study, the PDxBR digital prognostic model demonstrated robust performance in stratifying recurrence risk among patients with early-stage HR+/HER2- breast cancer treated according to ESMO and Dutch national guidelines. Despite differences in clinical risk profiles, follow-up duration, and event types compared to the original validation cohort, PDxBR maintained prognostic accuracy and outperformed traditional clinical models, including one based on the MINDACT trial. By integrating clinicopathologic variables with AI-derived histologic features, the PDxBR model offers a reproducible and scalable alternative to genomic assays. Furthermore, PDxBR effectively reclassified grade 2 tumors, which are often challenging to interpret using conventional grading, into biologically meaningful risk groups. These findings support the clinical utility of PDxBR as a decision-support tool for individualized risk assessment and highlight the potential of digital pathology to enhance precision oncology in breast cancer.</p></section><section id="Sec13"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12369158/bin/13058_2025_2104_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (665.6KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>JetPub Scientific Communications, LLC, assisted the authors in the preparation of this manuscript.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>AI</dt>
<dd><p id="Par57">Artificial intelligence</p></dd>
<dt>AUC</dt>
<dd><p id="Par58">Area under the curve</p></dd>
<dt>ASCO</dt>
<dd><p id="Par59">American Society of Clinical Oncology</p></dd>
<dt>CI</dt>
<dd><p id="Par60">Confidence interval</p></dd>
<dt>C-index</dt>
<dd><p id="Par61">Concordance index</p></dd>
<dt>ER+</dt>
<dd><p id="Par62">Estrogen receptor-positive</p></dd>
<dt>ESMO</dt>
<dd><p id="Par63">European Society for Medical Oncology</p></dd>
<dt>EU</dt>
<dd><p id="Par64">European Union</p></dd>
<dt>H&amp;E</dt>
<dd><p id="Par65">Hematoxylin and eosin</p></dd>
<dt>HER2-</dt>
<dd><p id="Par66">Human epidermal growth factor receptor 2-negative</p></dd>
<dt>HR+</dt>
<dd><p id="Par67">Hormone receptor-positive</p></dd>
<dt>ID</dt>
<dd><p id="Par68">Identifier</p></dd>
<dt>MINDACT</dt>
<dd><p id="Par69">MINDACT trial variables</p></dd>
<dt>NA</dt>
<dd><p id="Par70">Not applicable</p></dd>
<dt>NCCN</dt>
<dd><p id="Par71">National Comprehensive Cancer Network</p></dd>
<dt>NPV</dt>
<dd><p id="Par72">Negative predictive value</p></dd>
<dt>NGS</dt>
<dd><p id="Par73">Nottingham Grading System</p></dd>
<dt>NTH</dt>
<dd><p id="Par74">Netherlands</p></dd>
<dt>PDxBR</dt>
<dd><p id="Par75">PreciseBreast</p></dd>
<dt>PPV</dt>
<dd><p id="Par76">Positive predictive value</p></dd>
<dt>PR</dt>
<dd><p id="Par77">Progesterone receptor</p></dd>
<dt>SD</dt>
<dd><p id="Par78">Standard deviation</p></dd>
<dt>SE</dt>
<dd><p id="Par79">Sensitivity</p></dd>
<dt>SHAP</dt>
<dd><p id="Par80">SHapley Additive exPlanations</p></dd>
<dt>SP</dt>
<dd><p id="Par81">Specificity</p></dd>
<dt>TRIPOD</dt>
<dd><p id="Par82">Transparent Reporting Individual Prognosis or Diagnosis</p></dd>
<dt>US</dt>
<dd><p id="Par83">United States</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>P.W. and C.M. were involved with conceptualization, identification of the cohort, coordinating access to digital images and clinical data for the study, and final review/edits of the draft for submission. G.F., M.P., A.S.M., A.F, J.C.C and A.S. were involved with methodology, investigation, and visualization; X.Z. contributed to methodology and investigation, clinical data quality control, and generation of all performance metrics, figures, and tables. B.V. coordinated receipt of clinical data and performed quality control for methodology and investigation. R.D.A. contributed to conceptualization and follow-through. M.J.D. contributed to conceptualization, methodology, writing of the original draft, and visualization. All authors have read and approved this manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This study was funded by PreciseDx.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par54">The study was approved for academic research by a data use agreement between Stichting Albert Schweitzer Ziekenhuis and PreciseDx with applicable data protection law (GDPR) and locally applicable data protection legislation. All clinical data and H&amp;E-stained images from patient slides were completely de-identified prior to submission to PreciseDx. The Stichting Albert Schweitzer Ziekenhuis institutional review board approved the use of human patient specimens and their clinical data for this study and waived informed consent.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par55">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par56">G.F., M.P., A.S.M., A.F., J.C.M., B.V., A.S., X.Z. and M.J.D. are employees of, or receive monetary compensation, including stock options, in PreciseDx. M.J.D. and G.F. are scientific founders of the company. G.F. and M.J.D. are officers of PreciseDx. P.W., C.M., and R.D.A. have no conflicts to disclose.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Andre F, Nofisat Ismaila;, Allison KH, Barlow WE, Collyar DE, Damodaran S et al. Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update [Internet]. 2022. Available from: <a href="http://www.asco.org/breast-cancer-guidelines" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.asco.org/breast-cancer-guidelines</a></cite> [<a href="https://doi.org/10.1200/JCO.22.00069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35439025/" class="usa-link">PubMed</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. Breast cancer, version 3.2024. JNCCN J Natl Compr Cancer Netw. 2024;22:331–57.</cite> [<a href="https://doi.org/10.6004/jnccn.2024.0035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39019058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gradishar%20WJ,%20Moran%20MS,%20Abraham%20J,%20Abramson%20V,%20Aft%20R,%20Agnese%20D,%20et%20al.%20Breast%20cancer,%20version%203.2024.%20JNCCN%20J%20Natl%20Compr%20Cancer%20Netw.%202024;22:331%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Loibl S, André F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, Guidelines Committee. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 5 behalf of the ESMO. 2024;46. Available from: 10.1016/j.annonc.2023.11.016</cite>
</li>
<li id="CR4">
<span class="label">4.</span><cite>Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
</cite> [<a href="https://doi.org/10.3322/caac.21834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38572751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bray%20F,%20Laversanne%20M,%20Sung%20H,%20Ferlay%20J,%20Siegel%20RL,%20Soerjomataram%20I,%20et%20al.%20Global%20cancer%20statistics%202022:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries.%20CA%20Cancer%20J%20Clin.%202024;74:229%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med [Internet]. 2025; Available from: <a href="http://www.ncbi.nlm.nih.gov/pubmed/39994475" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.ncbi.nlm.nih.gov/pubmed/39994475</a></cite> [<a href="https://doi.org/10.1038/s41591-025-03502-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39994475/" class="usa-link">PubMed</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A, Cancer statistics. 2025. CA Cancer J Clin [Internet]. 2025; Available from: <a href="http://www.ncbi.nlm.nih.gov/pubmed/39817679" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.ncbi.nlm.nih.gov/pubmed/39817679</a></cite> [<a href="https://doi.org/10.3322/caac.21871" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11745215/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39817679/" class="usa-link">PubMed</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Pedersen RN, Esen BÖ, Mellemkjær L, Christiansen P, Ejlertsen B, Lash TL, et al. The incidence of breast cancer recurrence 10–32 years after primary diagnosis. J Natl Cancer Inst. 2022;114:391–9.
</cite> [<a href="https://doi.org/10.1093/jnci/djab202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8902439/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34747484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pedersen%20RN,%20Esen%20B%C3%96,%20Mellemkj%C3%A6r%20L,%20Christiansen%20P,%20Ejlertsen%20B,%20Lash%20TL,%20et%20al.%20The%20incidence%20of%20breast%20cancer%20recurrence%2010%E2%80%9332%20years%20after%20primary%20diagnosis.%20J%20Natl%20Cancer%20Inst.%202022;114:391%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Pistilli B, Lohrisch C, Sheade J, Fleming GF. Personalizing adjuvant endocrine therapy for Early-Stage hormone Receptor–Positive breast cancer. Am Soc Clin Oncol Educational Book. 2022;60–72.</cite> [<a href="https://doi.org/10.1200/EDBK_350358" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35623026/" class="usa-link">PubMed</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Venetis K, Pescia C, Cursano G, Frascarelli C, Mane E, De Camilli E et al. The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy. Int J Mol Sci. Multidisciplinary Digital Publishing Institute (MDPI); 2024.</cite> [<a href="https://doi.org/10.3390/ijms25115717" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11172282/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38891906/" class="usa-link">PubMed</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Varga Z, Sinn P, Seidman AD. Summary of head-to-head comparisons of patient risk classifications by the 21-gene Recurrence Score<sup>®</sup> (RS) assay and other genomic assays for early breast cancer. Int J Cancer. Wiley-Liss Inc.; 2019. pp. 882–93.</cite> [<a href="https://doi.org/10.1002/ijc.32139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30653259/" class="usa-link">PubMed</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Sparano JA, Crager MR, Gong Tang;, Gray RJ, Stemmer SM, Shak S. Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer. J Clin Oncol [Internet]. 2020;39:557–64. Available from: 10.1200/JCO.20.03007</cite> [<a href="https://doi.org/10.1200/JCO.20.03007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8078482/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33306425/" class="usa-link">PubMed</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Sparano JA, Crager M, Gray RJ, Tang G, Hoag J, Baehner FL et al. Clinical and genomic risk for late breast cancer recurrence and survival. NEJM Evid. 2024;3.</cite> [<a href="https://doi.org/10.1056/EVIDoa2300267" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11730053/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39041867/" class="usa-link">PubMed</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Pusztai L, Hoag JR, Albain KS, Barlow WE, Stemmer SM, Meisner A, et al. Development and validation of the RSClinN + Tool to predict prognosis and chemotherapy benefit for hormone Receptor-Positive, Node-Positive breast cancer. J Clin Oncol. 2025;43:919–28.
</cite> [<a href="https://doi.org/10.1200/JCO-24-01507" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11885031/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39621968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pusztai%20L,%20Hoag%20JR,%20Albain%20KS,%20Barlow%20WE,%20Stemmer%20SM,%20Meisner%20A,%20et%20al.%20Development%20and%20validation%20of%20the%20RSClinN%E2%80%89+%E2%80%89Tool%20to%20predict%20prognosis%20and%20chemotherapy%20benefit%20for%20hormone%20Receptor-Positive,%20Node-Positive%20breast%20cancer.%20J%20Clin%20Oncol.%202025;43:919%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Zeng C, Zhang J. A narrative review of five multigenetic assays in breast cancer. Transl cancer res. AME Publishing Company; 2022. pp. 897–907.</cite> [<a href="https://doi.org/10.21037/tcr-21-1920" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9091014/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35571670/" class="usa-link">PubMed</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Ji JH, Ahn SG, Yoo Y, Park SY, Kim JH, Jeong JY et al. Prediction of a Multi-Gene assay (Oncotype DX and Mammaprint) recurrence risk group using machine learning in Estrogen Receptor-Positive, HER2-Negative breast Cancer—The BRAIN study. Cancers (Basel). 2024;16.</cite> [<a href="https://doi.org/10.3390/cancers16040774" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10887075/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38398165/" class="usa-link">PubMed</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Fernandez G, Zeineh J, Prastawa M, Scott R, Madduri AS, Shtabsky A, et al. Analytical validation of the precisedx digital prognostic breast cancer test in Early-Stage breast cancer. Clin Breast Cancer. 2024;24:93–e1026.
</cite> [<a href="https://doi.org/10.1016/j.clbc.2023.10.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38114366/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fernandez%20G,%20Zeineh%20J,%20Prastawa%20M,%20Scott%20R,%20Madduri%20AS,%20Shtabsky%20A,%20et%20al.%20Analytical%20validation%20of%20the%20precisedx%20digital%20prognostic%20breast%20cancer%20test%20in%20Early-Stage%20breast%20cancer.%20Clin%20Breast%20Cancer.%202024;24:93%E2%80%93e1026." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Fernandez G, Prastawa M, Madduri AS, Scott R, Marami B, Shpalensky N et al. Development and validation of an AI-enabled digital breast cancer assay to predict early-stage breast cancer recurrence within 6 years. Breast Cancer Res. 2022;24.</cite> [<a href="https://doi.org/10.1186/s13058-022-01592-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9764637/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36539895/" class="usa-link">PubMed</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Masud SF, Mark N, Goss T, Malinowski D, Schnitt SJ, Sparano JA et al. U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancer. J Med Econ [Internet]. 2024 [cited 2025 Jul 1];27:972–81. Available from: <a href="https://www.tandfonline.com/doi/pdf/10.1080/13696998.2024.2379211" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.tandfonline.com/doi/pdf/10.1080/13696998.2024.2379211</a></cite> [<a href="https://doi.org/10.1080/13696998.2024.2379211" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39010830/" class="usa-link">PubMed</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Rakha EA, Tse GM, Quinn CM. An update on the pathological classification of breast cancer. Histopathology. John Wiley and Sons Inc; 2023. pp. 5–16.</cite> [<a href="https://doi.org/10.1111/his.14786" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10108289/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36482272/" class="usa-link">PubMed</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Ginter PS, Idress R, D’Alfonso TM, Fineberg S, Jaffer S, Sattar AK, et al. Histologic grading of breast carcinoma: a multi-institution study of interobserver variation using virtual microscopy. Mod Pathol. 2021;34:701–9.
</cite> [<a href="https://doi.org/10.1038/s41379-020-00698-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7987728/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33077923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ginter%20PS,%20Idress%20R,%20D%E2%80%99Alfonso%20TM,%20Fineberg%20S,%20Jaffer%20S,%20Sattar%20AK,%20et%20al.%20Histologic%20grading%20of%20breast%20carcinoma:%20a%20multi-institution%20study%20of%20interobserver%20variation%20using%20virtual%20microscopy.%20Mod%20Pathol.%202021;34:701%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Cardoso F, van’t Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, et al. 70-Gene signature as an aid to treatment decisions in Early-Stage breast cancer. N Engl J Med. 2016;375:717–29.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1602253" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27557300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cardoso%20F,%20van%E2%80%99t%20Veer%20LJ,%20Bogaerts%20J,%20Slaets%20L,%20Viale%20G,%20Delaloge%20S,%20et%20al.%2070-Gene%20signature%20as%20an%20aid%20to%20treatment%20decisions%20in%20Early-Stage%20breast%20cancer.%20N%20Engl%20J%20Med.%202016;375:717%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Mantrala S, Ginter PS, Mitkari A, Joshi S, Prabhala H, Ramachandra V, et al. Concordance in breast cancer grading by artificial intelligence on whole slide images compares with a Multi-Institutional cohort of breast pathologists. Arch Pathol Lab Med. 2022;146:1369–77.
</cite> [<a href="https://doi.org/10.5858/arpa.2021-0299-OA" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35271701/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mantrala%20S,%20Ginter%20PS,%20Mitkari%20A,%20Joshi%20S,%20Prabhala%20H,%20Ramachandra%20V,%20et%20al.%20Concordance%20in%20breast%20cancer%20grading%20by%20artificial%20intelligence%20on%20whole%20slide%20images%20compares%20with%20a%20Multi-Institutional%20cohort%20of%20breast%20pathologists.%20Arch%20Pathol%20Lab%20Med.%202022;146:1369%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Elmore JG, Longton GM, Carney PA, Geller BM, Onega T, Tosteson ANA, et al. Diagnostic concordance among pathologists interpreting breast biopsy specimens. JAMA - J Am Med Association. 2015;313:1122–32.</cite> [<a href="https://doi.org/10.1001/jama.2015.1405" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4516388/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25781441/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Elmore%20JG,%20Longton%20GM,%20Carney%20PA,%20Geller%20BM,%20Onega%20T,%20Tosteson%20ANA,%20et%20al.%20Diagnostic%20concordance%20among%20pathologists%20interpreting%20breast%20biopsy%20specimens.%20JAMA%20-%20J%20Am%20Med%20Association.%202015;313:1122%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Filipits M, Rudas M, Jakesz R, Dubsky P, Fitzal F, Singer CF, et al. A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. Clin Cancer Res. 2011;17:6012–20.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-11-0926" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21807638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Filipits%20M,%20Rudas%20M,%20Jakesz%20R,%20Dubsky%20P,%20Fitzal%20F,%20Singer%20CF,%20et%20al.%20A%20new%20molecular%20predictor%20of%20distant%20recurrence%20in%20ER-positive,%20HER2-negative%20breast%20cancer%20adds%20independent%20information%20to%20conventional%20clinical%20risk%20factors.%20Clin%20Cancer%20Res.%202011;17:6012%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Rawat RR, Ruderman D, Macklin P, Rimm DL, Agus DB. Correlating nuclear morphometric patterns with Estrogen receptor status in breast cancer pathologic specimens. NPJ Breast Cancer. 2018;4.</cite> [<a href="https://doi.org/10.1038/s41523-018-0084-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6123433/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30211313/" class="usa-link">PubMed</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Pons L, Hernández-León L, Altaleb A, Ussene E, Iglesias R, Castillo A et al. Conventional and digital Ki67 evaluation and their correlation with molecular prognosis and morphological parameters in luminal breast cancer. Sci Rep. 2022;12.</cite> [<a href="https://doi.org/10.1038/s41598-022-11411-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9114341/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35581229/" class="usa-link">PubMed</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Pescia C, Guerini-Rocco E, Viale G, Fusco N. Advances in early breast cancer risk profiling: from histopathology to molecular technologies. cancers (Basel). Multidisciplinary Digital Publishing Institute (MDPI); 2023.</cite> [<a href="https://doi.org/10.3390/cancers15225430" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10670146/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38001690/" class="usa-link">PubMed</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Sharma A, Lövgren SK, Eriksson KL, Wang Y, Robertson S, Hartman J et al. Validation of an AI-based solution for breast cancer risk stratification using routine digital histopathology images. Breast Cancer Research [Internet]. 2024 [cited 2025 Jul 9];26:1–10. Available from: <a href="https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-024-01879-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-024-01879-6</a></cite> [<a href="https://doi.org/10.1186/s13058-024-01879-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11323658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39143539/" class="usa-link">PubMed</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Witowski J, Zeng KG, Cappadona J, Elayoubi J, Choucair K, Chiru ED et al. Multi-modal AI for comprehensive breast cancer prognostication. 2024 [cited 2025 Jul 9]; Available from: <a href="https://arxiv.org/pdf/2410.21256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://arxiv.org/pdf/2410.21256</a></cite>
</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12369158/bin/13058_2025_2104_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (665.6KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Breast Cancer Research : BCR are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s13058-025-02104-8"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/13058_2025_Article_2104.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12369158/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12369158/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369158%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369158/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12369158/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12369158/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40836358/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12369158/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40836358/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12369158/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12369158/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="j8E4bNMXJ076glxBUFVqYJf3WTJ1qK6Aaq8TMESvbXmjpVz0dv1SxfYu6jmOTMJT">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
